These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35020476)

  • 21. Characterizing Glycemic Control and Sleep in Adults with Long-Standing Type 1 Diabetes and Hypoglycemia Unawareness Initiating Hybrid Closed Loop Insulin Delivery.
    Malone SK; Peleckis AJ; Grunin L; Yu G; Jang S; Weimer J; Lee I; Rickels MR; Goel N
    J Diabetes Res; 2021; 2021():6611064. PubMed ID: 33628834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
    Abraham MB; de Bock M; Smith GJ; Dart J; Fairchild JM; King BR; Ambler GR; Cameron FJ; McAuley SA; Keech AC; Jenkins A; Davis EA; O'Neal DN; Jones TW;
    JAMA Pediatr; 2021 Dec; 175(12):1227-1235. PubMed ID: 34633418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.
    Buckingham BA; Forlenza GP; Pinsker JE; Christiansen MP; Wadwa RP; Schneider J; Peyser TA; Dassau E; Lee JB; O'Connor J; Layne JE; Ly TT
    Diabetes Technol Ther; 2018 Apr; 20(4):257-262. PubMed ID: 29431513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Commercial hybrid closed-loop systems available for a patient with type 1 diabetes in 2022.
    Seget S; Tekielak A; Rusak E; Jarosz-Chobot P
    Pediatr Endocrinol Diabetes Metab; 2023; 29(1):30-36. PubMed ID: 37218723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hybrid Closed-loop to Manage Gastroparesis in People With Type 1 Diabetes: a Case Series.
    Daly A; Hartnell S; Boughton CK; Evans M
    J Diabetes Sci Technol; 2021 Nov; 15(6):1216-1223. PubMed ID: 34378426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-World Improvements in Hypoglycemia in an Insulin-Dependent Cohort With Diabetes Mellitus Pre/Post Tandem Basal-Iq Technology Remote Software Update.
    Pinsker JE; Leas S; Müller L; Habif S
    Endocr Pract; 2020 Jul; 26(7):714-721. PubMed ID: 33471639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Comparison of Two Hybrid Closed-Loop Systems in Italian Children and Adults With Type 1 Diabetes.
    Bassi M; Teliti M; Lezzi M; Iosca A; Strati MF; Carmisciano L; d'Annunzio G; Minuto N; Maggi D
    Front Endocrinol (Lausanne); 2021; 12():802419. PubMed ID: 35116007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-world outcomes with different technology modalities in type 1 diabetes.
    Beato-Víbora PI; Gallego-Gamero F; Ambrojo-López A
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1845-1850. PubMed ID: 33838993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real world use of hybrid-closed loop in children and young people with type 1 diabetes mellitus-a National Health Service pilot initiative in England.
    Ng SM; Wright NP; Yardley D; Campbell F; Randell T; Trevelyan N; Ghatak A; Hindmarsh PC
    Diabet Med; 2023 Feb; 40(2):e15015. PubMed ID: 36424877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Temporary Glycemic Target Use in the Hybrid and Advanced Hybrid Closed-Loop Systems.
    Dovc K; Battelino T; Beck RW; Sibayan J; Bailey RJ; Calhoun P; Turcotte C; Weinzimer S; Smigoc Schweiger D; Nimri R; Bergenstal RM
    Diabetes Technol Ther; 2022 Nov; 24(11):848-852. PubMed ID: 35848991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-year follow-up comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes.
    Bassi M; Patti L; Silvestrini I; Strati MF; Ponzano M; Minuto N; Maggi D
    Front Endocrinol (Lausanne); 2023; 14():1099024. PubMed ID: 36777356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and Their Parents.
    Cobry EC; Hamburger E; Jaser SS
    Diabetes Technol Ther; 2020 Nov; 22(11):794-800. PubMed ID: 32212971
    [No Abstract]   [Full Text] [Related]  

  • 34. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study.
    Sharifi A; De Bock MI; Jayawardene D; Loh MM; Horsburgh JC; Berthold CL; Paramalingam N; Bach LA; Colman PG; Davis EA; Grosman B; Hendrieckx C; Jenkins AJ; Kumareswaran K; Kurtz N; Kyoong A; MacIsaac RJ; Speight J; Trawley S; Ward GM; Roy A; Jones TW; O'Neal DN
    Diabetes Technol Ther; 2016 Dec; 18(12):772-783. PubMed ID: 27835037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and Safety of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes Previously Treated with Continuous Subcutaneous Insulin Infusion and Flash Glucose Monitoring.
    Gros Herguido N; Amuedo S; Bellido V; López Gallardo G; Losada F; Pérez Morales A; Ruiz Trillo CA; Soto Moreno A
    Diabetes Technol Ther; 2023 Feb; 25(2):151-156. PubMed ID: 36108305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceptions of Diabetes Technology Use in Cystic Fibrosis-Related Diabetes Management.
    Marks BE; Kilberg MJ; Aliaj E; Fredkin K; Hudson J; Riva D; Román C; Kelly A; Putman MS
    Diabetes Technol Ther; 2021 Nov; 23(11):753-759. PubMed ID: 34185606
    [No Abstract]   [Full Text] [Related]  

  • 37. Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system.
    Ekhlaspour L; Forlenza GP; Chernavvsky D; Maahs DM; Wadwa RP; Deboer MD; Messer LH; Town M; Pinnata J; Kruse G; Kovatchev BP; Buckingham BA; Breton MD
    Pediatr Diabetes; 2019 Sep; 20(6):759-768. PubMed ID: 31099946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-Year Real-World Study on Comparison among Different Continuous Subcutaneous Insulin Infusion Devices for the Management of Pediatric Patients with Type 1 Diabetes: The Supremacy of Hybrid Closed-Loop Systems.
    Bombaci B; Passanisi S; Alibrandi A; D'Arrigo G; Patroniti S; Averna S; Salzano G; Lombardo F
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting Success with a First-Generation Hybrid Closed-Loop Artificial Pancreas System Among Children, Adolescents, and Young Adults with Type 1 Diabetes: A Model Development and Validation Study.
    Forlenza GP; Vigers T; Berget C; Messer LH; Lal RA; Basina M; Maahs DM; Hood K; Buckingham B; Wilson DM; Wadwa RP; Driscoll KA; Pyle L
    Diabetes Technol Ther; 2022 Mar; 24(3):157-166. PubMed ID: 34780306
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Based on Total Daily Insulin in Adolescents with Type 1 Diabetes.
    Schoelwer MJ; Robic JL; Gautier T; Fabris C; Carr K; Clancy-Oliveri M; Brown SA; Anderson SM; DeBoer MD; Cherñavvsky DR; Breton MD
    Diabetes Technol Ther; 2020 Aug; 22(8):594-601. PubMed ID: 32119790
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.